Keywords: sb, sales, jump, fuelled, new, drugs, smithkline
SB Sales Jump 8%, Fuelled By New Drugs
Article | 24 October 1994
SmithKline Beecham's sales for third-quarter 1994 increased 8% to L1.59 billion ($2.43 billion), with new pharmaceutical product sales reaching L226 million, up 83% on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
